Jazz Pharmaceuticals plc buy The Goldman Sachs Group, Inc.
Start price
03.03.23
/
50%
€137.36
Target price
03.03.24
€199.47
Performance (%)
-19.63%
End price
04.03.24
€110.40
Summary
This prediction ended on 04.03.24 with a price of €110.40. The price of Jazz Pharmaceuticals plc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.63%. The_Goldman_Sachs_Gr has a follow-up prediction for Jazz Pharmaceuticals plc where he still thinks Jazz Pharmaceuticals plc is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Jazz Pharmaceuticals plc | 1.021% | 1.021% | -11.954% |
iShares Core DAX® | -3.935% | -2.628% | 10.013% |
iShares Nasdaq 100 | -3.608% | -9.283% | 20.668% |
iShares Nikkei 225® | -4.513% | -6.951% | 5.241% |
iShares S&P 500 | -2.607% | -4.402% | 20.177% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $190.00 to $212.00. They now have a "buy" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
In the thread Trading Jazz Pharmaceuticals plc
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€98.06
05.06.24
05.06.24
€155.23
05.06.25
05.06.25
5.90%
02.08.24
02.08.24